CB
Cahill Brian Joseph
Chief Financial Officer
OtherM
Insider track record
CFOAcross 6 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Browse the detailed record of transactions filed by Cahill Brian Joseph, Chief Financial Officer. Insider active across 1 company, notably Eagle Pharmaceuticals, INC.. Aggregated, 15 reports have been recorded. History available since 20 December 2021. The latest transaction was filed on 27 February 2024 (Attribution). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Cahill Brian Joseph
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations15 total
3,800 shares0Common StockSEC:0001415889-24-006003:0
934 shares@ US$5.851.4% of flowCommon StockSEC:0001415889-24-002831:0
735 shares@ US$5.131.0% of flowCommon StockSEC:0001209191-24-001256:0
452 shares@ US$4.760.6% of flowCommon StockSEC:0001209191-23-059344:0
718 shares@ US$28.005.3% of flowCommon StockSEC:0001209191-23-014650:0
785 shares@ US$34.096.8% of flowCommon StockSEC:0001209191-23-007318:0
601 shares@ US$33.215.1% of flowCommon StockSEC:0001209191-23-005795:0
734 shares@ US$29.265.7% of flowCommon StockSEC:0001209191-23-002569:0
461 shares@ US$30.033.7% of flowCommon StockSEC:0001209191-22-062331:0
8,000 shares0Common StockSEC:0001209191-22-015022:0
805 shares@ US$45.030.98% mcap12.8% of flowCommon StockSEC:0001209191-22-007224:0
626 shares@ US$45.940.78% mcap10.2% of flowCommon StockSEC:0001209191-22-006048:0
263 shares@ US$50.630.36% mcap4.7% of flowCommon StockSEC:0001209191-22-002882:0
738 shares@ US$50.691.01% mcap13.2% of flowCommon StockSEC:0001209191-22-002417:0
467 shares@ US$55.420.70% mcap9.1% of flowCommon StockSEC:0001209191-21-070845:0
About Cahill Brian Joseph
Brian Joseph Cahill is the Chief Financial Officer of EAGLE PHARMACEUTICALS, INC. He is responsible for the financial management of the company, including budgeting and financial reporting, to ensure its sustainable growth.